Bolivia Biomedical Equipment Declaration: Section 2.9 and the Five-Year Spare Parts Commitment

1. Key takeaways

Section 2.9 of the Manual requires that, for biomedical equipment, the manufacturer or the Bolivian representative issues an additional declaration containing four commitments: that the equipment is not experimental; that spare parts and maintenance supply will be provided for no less than 5 years, or for the lifetime of the equipment if that is shorter; that training will be provided; and that manuals will be provided in both the original language and Spanish. In addition, the certificate holder must report annually the number and location of the equipment installed. GRZAN’s assessment is that the substance of this declaration is a performance obligation lasting 5 years, and its cost should be built into the quotation at the pricing stage rather than being treated as a one-page paperwork exercise. The declaration is legally binding when signed, and each of its four commitments can be tested in practice: a spare parts gap, an untrained user base or a missing manual set can each surface during inspection or in correspondence with AGEMED, converting a routine document into a source of regulatory exposure. Because the declaration binds the certificate holder for years, its wording should be reviewed with the same care as a commercial contract, and the importer should understand it as a shared obligation, since the reporting and service commitments depend on local cooperation. The declaration should be signed only after each of the four commitments has been checked against actual capability.

2. Legal basis

3. Expert insights

Insight one: the not experimental declaration is a market access threshold in its own right. It requires the company to confirm that the equipment is not a trial product. For innovative devices that have only recently been approved in their home market, this item can become a real obstacle, because the company must be able to demonstrate that the equipment has completed development confirmation and entered routine commercial supply. Evidence such as commercial shipment records, a traceable installation base and the existence of standard production documentation supports this confirmation. Companies should assess their ability to make this statement honestly before submitting, since declaring it without the underlying facts creates exposure that extends beyond the Bolivian market. Where the equipment is new, the gap between development completion and routine supply should be closed in the home market first, or supported by supply evidence from other markets, before the filing is made. Where the equipment is supplied under a tender, the tender terms should also be checked for compatibility with the service commitments.

Insight two: the 5-year spare parts and maintenance commitment carries financial weight. The standard given in the provision is 5 years, or the lifetime of the equipment, whichever is shorter. This means the company must arrange spare parts inventory, local repair capability and personnel training over a 5-year horizon. For companies entering Bolivia on a project basis, this is the long-term cost most frequently underestimated, because project accounting tends to end at installation and commissioning. Building a service cost model covering the full commitment period, including logistics for parts and the availability of trained technicians in country, is the reliable way to price this obligation. The model should distinguish fixed commitments, such as training delivery, from variable ones, such as parts consumption, so that pricing remains valid as the installed base grows.

Insight three: the annual installed-base report turns the equipment into a trackable asset. The certificate holder reports the number and location of installed units each year, which gives AGEMED visibility of the distribution of the equipment across the country. This is infrastructure for technical vigilance, and it also means that transfers of equipment to new locations can generate reporting obligations. Companies and importers should agree in advance on the division of reporting duties, including who compiles the data, who submits it and on what schedule, so that hospital relocations or equipment sales do not silently break the annual reporting chain. The report format should follow the practice expected by AGEMED, and submission deadlines should be entered in the compliance calendar alongside the corporate annual review.

4. Practical recommendations

1. Include the cost of the 5-year spare parts and maintenance commitment in the quotation, and define a minimum inventory strategy for spare parts supply across the commitment period.
2. Divide the compilation and submission duties for the annual installed-base report with the importer in writing, so that a report is never missed through assumed responsibility.
3. Establish an internal register for equipment transfers and decommissioning, kept consistent with the figures reported in the annual submission, so that every location change is captured.
4. Archive the evidence supporting the not experimental statement, including commercial supply records, so that the commitment can be substantiated if AGEMED asks.

5. Verification checklist

• □ The product is a biomedical equipment item that triggers Section 2.9
• □ The four commitments, not experimental, 5-year spare parts and maintenance, training and dual-language manuals, are stated in the declaration
• □ The cost of the 5-year spare parts and maintenance commitment has been included in the quotation
• □ The compilation and submission duties for the annual installed-base report have been divided with the importer in writing
• □ Equipment transfer and decommissioning records have been incorporated into internal processes

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Bolivia for manufacturers, importers and authorized representatives, covering Section 2.9 declarations, service commitment planning, dossier assembly and regulatory correspondence. For assistance with biomedical equipment registration and the full process, contact info@grzanglobal.com.